BICYCLIC [4,6,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

The present invention relates to inhibitors of zinc-dependent histone deacetylases (HDACs) useful in the treatment of diseases or disorders associated with HDAC6, having a Formulae I or Formula II:where R, L, X1, X2, X3, X4, X5, Y1, Y2, Y3, and Y4 are described herein.

Saved in:
Bibliographic Details
Main Authors Lancia, JR., David R, Ng, Pui Yee, Rudnitskaya, Aleksandra, Zheng, Xiaozhang
Format Patent
LanguageEnglish
Published 09.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to inhibitors of zinc-dependent histone deacetylases (HDACs) useful in the treatment of diseases or disorders associated with HDAC6, having a Formulae I or Formula II:where R, L, X1, X2, X3, X4, X5, Y1, Y2, Y3, and Y4 are described herein.
Bibliography:Application Number: US202318196459